Dr. Erika P. Hamilton, MD

Dr. Hamilton practices at Nashville Oncology Associates in Brentwood, Tennessee.

Dr. Hamilton's NPI, 1902007107, was assigned on May 29, 2007. Dr. Hamilton graduated from University of North Carolina at Chapel Hill School of Medicine in 2007. Dr. Hamilton holds Tennessee license 49871.

Dr. Hamilton's primary practice is Nashville Oncology Associates, at 201 Franklin Rd, Brentwood, TN 37027 in Williamson County. The practice phone is (615) 329-7640.

Dr. Hamilton's primary practice is Nashville Oncology Associates in Brentwood, Tennessee. Dr. Hamilton is also affiliated with TriStar Centennial Medical Center. The medical group on file is Nashville Oncology Associates, PC. Dmand AI also links Dr. Hamilton to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hamilton practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Hamilton's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Hamilton's licenses on file in 2 states: Tennessee and North Carolina.

CMS data shows 5,786 Medicare services from Dr. Hamilton across 23 procedure codes in 2024, for 198 Medicare patients. Medicare paid $125,512 for them. Every service was in an office.

CMS counts 198 Medicare patients who saw Dr. Hamilton in 2024. The largest group is 65 to 74, with 114 patients. 75% of them have cancer, and 72% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hamilton's median patient age at 65, with 86% women.

In 2024, Dr. Hamilton wrote 267 Medicare Part D claims for 91 patients. 91% of them were for generic drugs. CMS names the drug for 109 of them, across 3 drugs with 11 or more claims each, at $2,591 in total drug cost. In 2023, CMS named 358 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Hamilton for performance year 2024, reported as part of a group. Dr. Hamilton accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 113 papers to Dr. Hamilton, published from 2010 to 2025. 2024 was the busiest year, with 18. The most frequent topics are Breast Neoplasms, Receptor, ErbB-2 and Antineoplastic Combined Chemotherapy Protocols. Dr. Hamilton has published most often in J Clin Oncol. Dr. Hamilton's most frequent co-authors are Sara A. Hurvitz, MD, Komal Jhaveri and Sara Michell Tolaney, MD.

Dmand AI links Dr. Hamilton to 17 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Endometrial Neoplasms. Eli Lilly and Company sponsors the most, 6. Open Payments lists research payments to Dr. Hamilton that name 8 trials.

CMS Open Payments shows 610 general payments to Dr. Hamilton from 69 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 59% of the total. Daiichi Sankyo Company LTD paid the most, $46,438. It also lists 98 research payments totaling $167,104 from 2018 to 2025, naming 8 clinical trials.

Dr. Hamilton graduated from University of North Carolina at Chapel Hill School of Medicine in 2007.